Arbutus biopharma corporation

Major-Pharmaceuticals

ABUS


100-8900 Glenlyon Parkway
Burnaby , BC V5J 5J8

Executive/
Director

Price

  • Last Close
  • $ 3.42
    $ +0.13 3.8 %
    Jan 3, 2025
  • 52-Week High/Low
  • $3.89 - $1.69
  • YTD
  • 0%

  • Trading Volume
  • 12,412
  • Market Cap Full
  • $ 573.5M
  • Shares Outstanding
  • 167.7M
    Nov 3, 2023
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Q1 32.7% -1% -6.5% -5% -6.2% -23% 30% 3.6% 4.1% -
Q2 10.8% 41.8% -44.3% 4% -9% -9.5% -24.1% 22% - -
Q3 72.2% 20.4% -32.1% 8% 41.6% -29.5% -11.7% 1.7% - -
Q4 -30.3% -60.4% 90% 13.4% -9.3% 22% 30.2% -11% - -
J F M A M J J A S O N D
2026 - - - - - - - - - - - -
2025 4.1% - - - - - - - - - - -
    2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
    -45%106%-24%-26%25%10%-40%7%31%4%0%

Earnings

2017 2018 2019 2020 2021 2022 2023
Q1 0.34 -0.36 -0.47 -0.25 -0.21 -0.11 -0.10
Q2 0.28 0.01 -0.46 -0.25 -0.23 -0.1 -0.10
Q3 0.17 -0.49 -1.5 -0.27 -0.24 -0.12 -0.12
Q4 0.90 -0.37 -0.46 -0.23 -0.15 -0.13 -
A 1.7 -1.2 -2.9 -1 -0.8 -0.5 -0.32

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 56.1 68.9 95.6 148.6 162.6
Jun 55.1 56.9 69 96.4 148.7 166.1
Sep 55.4 56.9 80.9 99.2 150 167.6
Dec 55.5 56.9 84.9 135.3 156.5 167.7

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 0.9 0.3 1 0.7 0.2
Total Asset Turnover 0.2 0.1 0.1 0.1 -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage -16.3 -37 -8.1 -14.4 2.7
Equity multiplier 0.3 0.3 0.1 0.1 0.2